SIPI-2011
N/A
Report date: 2024/09/04 20:00:55
NME
Base Information
Drug NameSIPI-2011
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Kanion Pharmaceutical Co LtdShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical IndustryJiangsu Kanion Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A